COMMUNIQUÉS West-GlobeNewswire
-
KFSH Highlights Innovation Infrastructure as the Foundation for Sustainable Healthcare Transformation at HLTH Europe 2026
16/06/2026 -
UBC MOSAIC and LifeLabs Unlock New Ways to Manage and Predict Heart Health
16/06/2026 -
FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose
16/06/2026 -
Comprehensive Healthcare implements ZING® robot for methadone dosing
16/06/2026 -
EssilorLuxottica et Applied Materials s’unissent pour faire progresser les dispositifs optiques de réalité augmentée destinés aux nouvelles générations de lunettes intelligentes
16/06/2026 -
EssilorLuxottica and Applied Materials Join Forces to Advance Augmented Reality Optics Platforms for Next-Generation Smart Glasses
16/06/2026 -
Trinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results
16/06/2026 -
Erdem Hospital Highlights Emotional Wellbeing as Part of Patient Care with London Wellness Event
16/06/2026 -
Nexalin Technology Announces Two Clinical Abstracts Accepted for Presentation at the 2026 NYC Neuromodulation Conference Highlighting Preliminary Clinical Results Across Anxiety, Depression, Insomnia and Quality of Life
16/06/2026 -
Pycnogenol® Brings a “Less-is-More” Approach to the Women’s Health Stack
16/06/2026 -
Creative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards
16/06/2026 -
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
16/06/2026 -
Confluent Health Launches The Pain Perspective, Revealing a New National Portrait of Chronic Pain in America
16/06/2026 -
Sharecare selected by Georgia Department of Community Health to advance rural health transformation through GREAT Health Program
16/06/2026 -
WORK Medical Announces 1-for-100 Reverse Stock Split Effective June 18, 2026
16/06/2026 -
Oncolytics Biotech® Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044
16/06/2026 -
Propanc Biopharma’s CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH Study
16/06/2026 -
Entera Reports Robust Preclinical Data for EB612 (Oral LA-PTH(1-34)) for Hypoparathyroidism and EB618 (Oral GLP-1/Glucagon) for Obesity at ENDO 2026
16/06/2026 -
GHK-Cu For Sale At Koi Peptides for Laboratory Use in 2026
16/06/2026
Pages